User fees for the Food and Drug Administration’s OTC monograph program will be part of the agency’s third consecutive budget with its fiscal year 2023 appropriation, but the fees and the operations of the program they support still are new to some in the industry.
The OTC monograph program overhauled to be more effective and efficient under 2020 legislation resembles the FDA’s process for prescription...